Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IRD | OPUS GENETICS INC | $43.07M | $0.95 | $7.00 | 639.18% | Buy | 2 | 51.24% | N/A | -148.82% | -27.15% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $157.30M | $0.70 | $5.17 | 638.14% | Buy | 6 | 14.57% | N/A | -75.69% | -16.96% | |||
| BLUE | BLUEBIRD BIO INC | $34.27M | $3.50 | $25.75 | 635.71% | Buy | 4 | 65.55% | N/A | N/A | -3.40% | |||
| SABS | SAB BIOTHERAPEUTICS INC | $16.63M | $1.79 | $13.00 | 626.26% | Strong Buy | 2 | 39.41% | N/A | -44.35% | -26.06% | |||
| CALC | CALCIMEDICA INC | $26.96M | $2.00 | $14.50 | 625.00% | Strong Buy | 2 | N/A | N/A | -9.36% | -6.81% | |||
| CMMB | CHEMOMAB THERAPEUTICS LTD | $23.76M | $1.26 | $9.00 | 614.29% | Strong Buy | 2 | N/A | N/A | -2,228.75% | -1,778.51% | |||
| IBIO | IBIO INC | $12.77M | $0.77 | $5.50 | 611.51% | Strong Buy | 2 | -46.67% | N/A | -208.29% | -124.09% | |||
| AUTL | AUTOLUS THERAPEUTICS PLC | $351.31M | $1.32 | $9.32 | 606.06% | Strong Buy | 5 | 215.68% | N/A | 8.98% | 4.46% | |||
| PRTA | PROTHENA CORP PUBLIC LTD CO | $399.93M | $7.43 | $51.71 | 596.02% | Buy | 7 | 12.62% | N/A | -17.63% | -15.58% | |||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $20.85M | $1.82 | $12.50 | 586.81% | Strong Buy | 2 | 286.74% | N/A | 43.39% | 31.22% | |||
| ATXS | ASTRIA THERAPEUTICS INC | $238.72M | $4.23 | $29.00 | 585.58% | Buy | 5 | N/A | N/A | -22.21% | -20.72% | |||
| VIGL | VIGIL NEUROSCIENCE INC | $112.95M | $2.42 | $16.33 | 574.92% | Buy | 3 | N/A | N/A | -59.00% | -35.86% | |||
| EVAX | EVAXION BIOTECH A | $2.09M | $1.49 | $10.00 | 571.14% | Strong Buy | 2 | 38.14% | N/A | -212.26% | 28.09% | |||
| OTLK | OUTLOOK THERAPEUTICS INC | $48.99M | $1.53 | $10.20 | 566.67% | Buy | 5 | N/A | N/A | -150.88% | 446.20% | |||
| RNXT | RENOVORX INC | $38.74M | $1.06 | $7.00 | 560.38% | Buy | 2 | 703.82% | N/A | 220.36% | 121.55% | |||
| VIR | VIR BIOTECHNOLOGY INC | $702.94M | $5.09 | $33.57 | 560.20% | Strong Buy | 7 | 49.96% | N/A | -13.04% | -10.41% | |||
| LFWD | LIFEWARD LTD | $14.56M | $1.37 | $9.00 | 556.93% | Strong Buy | 3 | 60.77% | N/A | 120.69% | 74.62% | |||
| GEVO | GEVO INC | $277.95M | $1.16 | $7.58 | 553.02% | Buy | 2 | 126.06% | N/A | 2.45% | 2.05% | |||
| AZUL | AZUL SA | $74.47M | $0.64 | $4.13 | 545.78% | Buy | 3 | 10.54% | N/A | -10.14% | 11.75% | |||
| CTSO | CYTOSORBENTS CORP | $54.44M | $0.87 | $5.50 | 531.46% | Buy | 2 | 13.08% | N/A | -39.39% | -9.24% | |||
| GOSS | GOSSAMER BIO INC | $252.22M | $1.11 | $7.00 | 530.63% | Strong Buy | 3 | -5.41% | N/A | 146.39% | 13.69% | |||
| IBRX | IMMUNITYBIO INC | $1.77B | $2.07 | $13.00 | 528.02% | Strong Buy | 4 | 209.26% | N/A | -25.60% | 32.70% | |||
| IMAB | I-MAB | $71.76M | $0.88 | $5.50 | 525.00% | Buy | 2 | N/A | N/A | -75.95% | -71.83% | |||
| ADAP | ADAPTIMMUNE THERAPEUTICS PLC | $75.52M | $0.29 | $1.83 | 524.57% | Buy | 5 | -8.07% | N/A | 781.53% | 37.65% | |||
| CTNM | CONTINEUM THERAPEUTICS INC | $100.12M | $3.87 | $23.75 | 513.70% | Strong Buy | 4 | N/A | N/A | -37.49% | -34.88% | |||
| TIL | INSTIL BIO INC | $86.34M | $13.23 | $81.00 | 512.24% | Strong Buy | 2 | N/A | N/A | -24.53% | -15.77% | |||
| CLSD | CLEARSIDE BIOMEDICAL INC | $66.27M | $0.86 | $5.25 | 511.18% | Strong Buy | 4 | 177.22% | N/A | -40.70% | 62.94% | |||
| VERV | VERVE THERAPEUTICS INC | $375.61M | $4.23 | $25.75 | 508.75% | Strong Buy | 4 | -20.16% | N/A | -43.55% | -33.19% | |||
| PYXS | PYXIS ONCOLOGY INC | $65.90M | $1.07 | $6.50 | 507.48% | Buy | 2 | -13.82% | N/A | -43.10% | -33.11% | |||
| ADCT | ADC THERAPEUTICS SA | $125.84M | $1.27 | $7.67 | 503.70% | Strong Buy | 3 | 24.05% | N/A | -3.42% | 2.15% | |||
| TARA | PROTARA THERAPEUTICS INC | $125.01M | $3.24 | $19.50 | 501.85% | Strong Buy | 4 | N/A | N/A | -31.28% | -29.41% | |||
| OLMA | OLEMA PHARMACEUTICALS INC | $314.33M | $4.60 | $27.67 | 501.46% | Strong Buy | 3 | N/A | N/A | -51.80% | -46.97% | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $753.09M | $6.99 | $42.00 | 500.86% | Strong Buy | 10 | N/A | N/A | -27.97% | -24.47% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.